JVSPAC ACQUISITION CORP-A (JVSA) Fundamental Analysis & Valuation

NASDAQ:JVSA • VGG5212E1051

Current stock price

3.64 USD
-7.06 (-65.98%)
At close:
4.05 USD
+0.41 (+11.26%)
After Hours:

This JVSA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. JVSA Profitability Analysis

1.1 Basic Checks

  • In the past year JVSA was profitable.
  • In the past year JVSA has reported a negative cash flow from operations.
JVSA Yearly Net Income VS EBIT VS OCF VS FCFJVSA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500K -500K 1M 1.5M 2M

1.2 Ratios

  • With a Return On Assets value of 3.29%, JVSA perfoms like the industry average, outperforming 55.77% of the companies in the same industry.
  • JVSA has a Return On Equity (3.42%) which is in line with its industry peers.
Industry RankSector Rank
ROA 3.29%
ROE 3.42%
ROIC N/A
ROA(3y)-5.71%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JVSA Yearly ROA, ROE, ROICJVSA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 50 100 150 200

1.3 Margins

  • JVSA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
JVSA Yearly Profit, Operating, Gross MarginsJVSA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

3

2. JVSA Health Analysis

2.1 Basic Checks

  • JVSA has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, JVSA has an improved debt to assets ratio.
JVSA Yearly Shares OutstandingJVSA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M
JVSA Yearly Total Debt VS Total AssetsJVSA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • JVSA has an Altman-Z score of 7.14. This indicates that JVSA is financially healthy and has little risk of bankruptcy at the moment.
  • JVSA has a better Altman-Z score (7.14) than 90.38% of its industry peers.
  • JVSA has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • JVSA's Debt to Equity ratio of 0.00 is amongst the best of the industry. JVSA outperforms 90.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.14
ROIC/WACCN/A
WACCN/A
JVSA Yearly LT Debt VS Equity VS FCFJVSA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • JVSA has a Current Ratio of 0.84. This is a bad value and indicates that JVSA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • JVSA has a worse Current ratio (0.84) than 76.92% of its industry peers.
  • A Quick Ratio of 0.84 indicates that JVSA may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.84, JVSA is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84
JVSA Yearly Current Assets VS Current LiabilitesJVSA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200K 400K 600K 800K

1

3. JVSA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 840.48% over the past year.
EPS 1Y (TTM)840.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.99%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. JVSA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 13.48 indicates a correct valuation of JVSA.
  • 92.31% of the companies in the same industry are more expensive than JVSA, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of JVSA to the average of the S&P500 Index (27.71), we can say JVSA is valued rather cheaply.
Industry RankSector Rank
PE 13.48
Fwd PE N/A
JVSA Price Earnings VS Forward Price EarningsJVSA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JVSA Per share dataJVSA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. JVSA Dividend Analysis

5.1 Amount

  • JVSA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

JVSA Fundamentals: All Metrics, Ratios and Statistics

JVSPAC ACQUISITION CORP-A

NASDAQ:JVSA (6/30/2025, 8:25:52 PM)

After market: 4.05 +0.41 (+11.26%)

3.64

-7.06 (-65.98%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-14
Earnings (Next)N/A
Inst Owners85.11%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap27.99M
Revenue(TTM)N/A
Net Income(TTM)2.09M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.48
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.46
P/tB 0.46
EV/EBITDA N/A
EPS(TTM)0.27
EY7.42%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS7.95
TBVpS7.95
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 3.29%
ROE 3.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.71%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z 7.14
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)840.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.99%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-160.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

JVSPAC ACQUISITION CORP-A / JVSA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for JVSPAC ACQUISITION CORP-A?

ChartMill assigns a fundamental rating of 2 / 10 to JVSA.


What is the valuation status of JVSPAC ACQUISITION CORP-A (JVSA) stock?

ChartMill assigns a valuation rating of 2 / 10 to JVSPAC ACQUISITION CORP-A (JVSA). This can be considered as Overvalued.


How profitable is JVSPAC ACQUISITION CORP-A (JVSA) stock?

JVSPAC ACQUISITION CORP-A (JVSA) has a profitability rating of 1 / 10.